Cefoxitin: Clinical Trials

2 trials of Cefoxitin, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed, 1 recruiting. 2 Phase 3, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 32Completed 1, Recruiting 1
Phase 21Recruiting 1

Follow Cefoxitin: new trials by email Literature Review of Cefoxitin trials Research Report on Cefoxitin

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Finding the Optimal Regimen for Mycobacterium Abscessus Treatment
Amikacin, Tigecycline, Imipenem - Pulmonary Disease Due to Mycobacteria (Diagnosis)
Phase 2 / Phase 3RecruitingThe University of Queensland3002020-03-022026-05-11
Does Cefoxitin or Piperacillin-Tazobactam Prevent Postoperative Surgical Site Infections After Pancreatoduodenectomy?
Cefoxitin, Piperacillin-tazobactam - Pancreatic Cancer, Pancreas Cancer
Phase 3CompletedMemorial Sloan Kettering Cancer Center9672017-11-212025-10-21

Conditions studied

Disease (1)  ·  Lung Diseases (1)  ·  Mycobacterium Infections, Nontuberculous (1)  ·  Pancreatic Diseases (1)  ·  Pancreatic Neoplasms (1)

Sponsors

Memorial Sloan Kettering Cancer Center (1)  ·  The University of Queensland (1)

Countries

Australia (1)  ·  Canada (1)  ·  Denmark (1)  ·  Israel (1)  ·  Netherlands (1)  ·  Singapore (1)  ·  Taiwan (1)  ·  United Kingdom (1)  ·  United States (1)

Top investigators

Michael D'Angelica, MD (1)

Results publications

PMID 33664081, PMID 37078771